Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis

Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis

Yu-Tuan Wu,1,* Zhou Xu,1,* Ke Zhang,2,* Jiu-song Wu,3,* Xin Li,1,* Bilal Arshad,1 Ying-Cun Li,3 Zhong-Liang Wang,2 Hong-Yuan Li,1 Kai-Nan Wu,1 Ling-Quan Kong1 1Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; 2Depart...

Full description

Bibliographic Details
Main Authors: Wu Y, Xu Z, Zhang K, Wu J, Li X, Arshad B, Li Y, Wang Z, Li H, Wu K, Kong L
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Breast cancer
HER2
Neoadjuvant chemotherapy
Trastuzumab
Anthracycline
Online Access:https://www.dovepress.com/efficacy-and-cardiac-safety-of-the-concurrent-use-of-trastuzumab-and-a-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/efficacy-and-cardiac-safety-of-the-concurrent-use-of-trastuzumab-and-a-peer-reviewed-article-TCRM

Similar Items